These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2866071)

  • 1. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study.
    Dickinson RJ; King A; Wight DG; Hunter JO; Neale G
    Dis Colon Rectum; 1985 Dec; 28(12):929-30. PubMed ID: 2866071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.
    Gilat T; Leichtman G; Delpre G; Eshchar J; Bar Meir S; Fireman Z
    J Clin Gastroenterol; 1989 Aug; 11(4):392-5. PubMed ID: 2569488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial.
    Gilat T; Suissa A; Leichtman G; Delpre G; Pavlotzky M; Grossman A; Fireman Z
    J Clin Gastroenterol; 1987 Aug; 9(4):415-7. PubMed ID: 2888801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
    Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
    Jewell DP; Ireland A
    Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
    Sutherland LR; May GR; Shaffer EA
    Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
    d'Albasio G; Trallori G; Ghetti A; Milla M; Nucci A; Pacini F; Morettini A
    Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
    Rijk MC; van Lier HJ; van Tongeren JH
    Am J Gastroenterol; 1992 Apr; 87(4):438-42. PubMed ID: 1348159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U; Maier K; Fischer C; Heinkel K
    N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
    Mulder CJ; Tytgat GN; Weterman IT; Dekker W; Blok P; Schrijver M; van der Heide H
    Gastroenterology; 1988 Dec; 95(6):1449-53. PubMed ID: 2903110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis.
    Fleig WE; Laudage G; Sommer H; Wellmann W; Stange EF; Riemann J
    Digestion; 1988; 40(3):173-80. PubMed ID: 2906888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ozone therapy combined with sulfasalazine delivered via a colon therapy system for treatment of ulcerative colitis].
    Geng Y; Wang W; Ma Q; Peng LQ; Liang ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2683-5. PubMed ID: 21177179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.
    Hermanowicz A; Nowak A; Gajos L
    Gut; 1984 May; 25(5):S34-8. PubMed ID: 6143709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.
    Dew MJ; Harries AD; Evans N; Evans BK; Rhodes J
    Br Med J (Clin Res Ed); 1983 Jul; 287(6384):23-4. PubMed ID: 6134565
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.